Streetbeat News

Products Services

SMMT

Summit Therapeutics has completed enrollment in its Phase III HARMONi trial for ivonescimab in EGFR-mutated NSCLC. The FDA has granted Fast Track designation for ivonescimab, with topline data expected in mid-2025.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 8:19 pm

UAVS

AgEagle Aerial Systems' eBee VISION participated in the REPMUS 2024 exercise, an annual event showcasing leaders in the UAS industry. The selection process for participation is rigorous, highlighting the company's prominence in the field.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 8:16 pm

EWJ

TM

VGK

Toyota and Subaru plan to launch jointly developed electric vehicles in Japan, the U.S., and Europe by 2026, according to Nikkei.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 8:15 pm

F

GM

STLA

TSLA

Republican Presidential Nominee Donald Trump announced that if elected, he will prevent states from banning gas-powered cars or trucks. This statement could impact the automotive industry, particularly companies involved in the production of gas-powered vehicles.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 8:13 pm

PSN

Parsons has been chosen by the National Guard Bureau to manage the operation and maintenance of a groundwater treatment system for per- and polyfluoroalkyl substances at the Burlington Air National Guard Base. The terms of the agreement were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 8:09 pm

TRVI

Trevi Therapeutics announced updates on its clinical development program for Haduvio, an investigational therapy for chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough (RCC). The Phase 2b CORAL trial has reached a 50% enrollment milestone, with sample size re-estimation results expected in December 2024. Additionally, the Human Abuse Potential study dosing is complete, with topline results also expected in December 2024.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 8:08 pm

IONQ

IonQ has achieved a significant milestone in quantum computing by demonstrating remote ion-ion entanglement, marking progress towards scalable quantum systems. This is the second of four milestones needed for developing photonic interconnects, crucial for quantum networking.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 8:02 pm

ABVX

Abivax has enrolled the first patient in its Phase 2b trial, ENHANCE-CD, for the drug Obefazimod, aimed at treating Crohn's Disease.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 8:01 pm

XOM

Exxon Mobil Corporation (NYSE:XOM) is highlighted as a potential beneficiary of rising oil prices due to political tensions in the Middle East. The stock is nearing a breakout point, suggesting a possible upward trend if it surpasses its resistance level.

Portfolio Pulse from Mark Putrino

October 03, 2024 | 7:59 pm

DIS

FOXA

Colin Cowherd compared the Detroit Lions to a relative who won't stop talking about cryptocurrency, highlighting the team's transition under coach Dan Campbell. Cowherd, who left Disney's ESPN for Fox Sports, discussed Campbell's need to evolve from an aggressive to a situationally elite coach.

Portfolio Pulse from Aaron Bry

October 03, 2024 | 7:42 pm